跳至主要内容
临床试验/IRCT20211109053014N1
IRCT20211109053014N1招募中3 期

Comparative efficacy and safety of rivaroxaban and subcutaneous enoxaparin in perevention of venous thrombo embolic events after spinal instrumentation

Esfahan University of Medical Sciences0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • All patients undergoing spinal cord surgery
  • Patient consent to participate in the study
  • High risk of the patient for venous thromboembolism

排除标准

  • Consumption of anticoagulants in the last 3 months
  • Urine test with purpura-positive blood or cutaneous hematoma with active bleeding or high risk of bleeding
  • Existence of active cancer as an underlying disease or cancer treated in the last 6 months
  • Hospitalization and inactivity for more than 3 days
  • Smoking more than 20 cigarettes a day
  • Having a body mass index higher than 35
  • Pulmonary embolism and lower venous thrombosis

研究者

相似试验